Reports from Advisory Board and Ethics Report year 4 (D8.11)
Authors/Creators
-
University Medical Center Utrecht
-
University of Ulster
- The European Insitute for Innovation Through Health Data
-
KU Leuven
-
Netherlands Pharmacovigilance Centre Lareb
-
Newcastle upon Tyne Hospitals NHS Foundation Trust
-
Janssen (Netherlands)
-
Novartis (Switzerland)
-
Sanofi (France)
-
GlaxoSmithKline (Switzerland)
-
UCB Pharma (France)
-
Takeda (Denmark)
Description
This deliverable contains the assessment, guidance, and recommendations from the members of the Advisory Board of ConcePTION on project activities and compliance of these activities with IMI regulations, ethics, and scientific standard procedures. It focuses on the progress of the project during the fourth year as well as the sustainability of ConcePTION and recommendations for finishing the project.
The feedback provided by each of the members of the Advisory Board is primarily based on the presentations and discussions which took place during the General Assembly meeting of ConcePTION in March 2023. Before this meeting, each Advisory Board member received some reading materials including the latest project publications, deliverables, a recording of a webinar on the ConcePTION webinar, and notes of the plans regarding sustainability. The current report also contains feedback and actions points provided from the Managing Team of ConcePTION.
The members of the Advisory Board agree that ethical standards for data collection, privacy protection and human participation are met in the ConcePTION project.
Files
D8.11 Reports from Advisory Board and Ethics Report year 4.pdf
Files
(226.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:6277649959ef9d1947d55562fd22568d
|
226.3 kB | Preview Download |